These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 2671932

  • 41. Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.
    Truog AW, Wozniak SP.
    Oncol Nurs Forum; 1990; 17(1):39-44. PubMed ID: 2405360
    [Abstract] [Full Text] [Related]

  • 42. Cyclosporin A versus methotrexate, followed by rescue with folinic acid as prophylaxis of acute graft-versus-host disease after bone marrow transplantation.
    Torres A, Martinez F, Gomez P, Herrera C, Rojas R, Gomez-Villagran JL, Garcia-Castellano JM, Velasco F, Andres P, Fornes G.
    Blut; 1989 Feb; 58(2):63-8. PubMed ID: 2645954
    [Abstract] [Full Text] [Related]

  • 43. Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT).
    Blaise D, Guyotat D, Reiffers J, Olive D, Michallet M, Bellanger C, Vernant JP, Ifrah N, Attal M, Vilmer E.
    Bone Marrow Transplant; 1991 Feb; 7 Suppl 2():150. PubMed ID: 1878689
    [No Abstract] [Full Text] [Related]

  • 44. Combination prophylactic immunosuppression in bone marrow transplantation.
    Szer J.
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3011-2. PubMed ID: 2650415
    [No Abstract] [Full Text] [Related]

  • 45. Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation.
    Hochhausen N, Altmaier EM, McQuellon R, Davies SM, Papadopolous E, Carter S, Henslee-Downey J.
    J Psychosoc Oncol; 2007 Feb; 25(1):87-101. PubMed ID: 17360317
    [Abstract] [Full Text] [Related]

  • 46. Prevention and treatment of acute graft-versus-host disease.
    Neudorf S, Filipovich A, Ramsay N, Kersey J.
    Semin Hematol; 1984 Apr; 21(2):91-100. PubMed ID: 6377502
    [No Abstract] [Full Text] [Related]

  • 47. [Prevention and treatment of acute graft-versus host disease].
    Hervé P.
    Presse Med; 1991 Oct 19; 20(33):1614-21. PubMed ID: 1835077
    [Abstract] [Full Text] [Related]

  • 48. Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates.
    Deeg HJ, Storb R, Appelbaum FR, Kennedy MS, Graham TC, Thomas ED.
    Transplantation; 1984 Jan 19; 37(1):62-5. PubMed ID: 6364490
    [Abstract] [Full Text] [Related]

  • 49. Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease.
    Mattsson T, Heimdahl A, Dahllöf G, Lönnquist B, Ringdén O.
    Oral Surg Oral Med Oral Pathol; 1992 Jul 19; 74(1):34-40. PubMed ID: 1508507
    [Abstract] [Full Text] [Related]

  • 50. Influence of graft-versus-host disease prophylaxis on early T-lymphocyte regeneration following allogeneic bone marrow transplantation.
    Gratama JW, Würsch AM, Nissen C, Gratwohl A, D'Amaro J, de Gast GC, van Rood JJ, Speck B.
    Br J Haematol; 1986 Feb 19; 62(2):355-65. PubMed ID: 3511949
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Cyclosporine: GVHD and beyond.
    Parkman R.
    N Engl J Med; 1988 Jul 14; 319(2):110-1. PubMed ID: 3380123
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Graft-versus-host disease after marrow transplantation.
    Lancet; 1984 Mar 03; 1(8375):491-2. PubMed ID: 6142212
    [No Abstract] [Full Text] [Related]

  • 56. [Utilisation of immunosuppressants in the prevention of a graft versus host reaction: report by the SFGM-TC].
    Belaiche S, Yafour N, Balcaen S, Beguin Y, Borel C, Bruno B, Godin S, Labussiere-Wallet H, Sanhamut N, Charbonnier A, de Berranger E, Konopacki-Potet J, Turlure P, Yakoub-Agha I, SFGM-TC.
    Pathol Biol (Paris); 2014 Aug 03; 62(4):197-203. PubMed ID: 25015585
    [Abstract] [Full Text] [Related]

  • 57. Prevention and therapy of graft-versus-host disease. Report from a work-shop.
    Ringdén O, Kersey JH.
    Bone Marrow Transplant; 1992 Aug 03; 10 Suppl 1():22-4. PubMed ID: 1355684
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Cyclosporin A as prophylaxis against graft-versus-host disease.
    Guyotat D, Morgenstern GR, Powles RL.
    Br Med J (Clin Res Ed); 1982 Nov 13; 285(6352):1424. PubMed ID: 6814585
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.